Events Archive
Peptimmune Presentation at upcoming World Congress on Treatment and Research in Multiple Sclerosis
Event Date: September 18, 2008
Dr. Joseph Kovalchin will make a poster presentation titled "EVIDENCE OF SPECIFIC T-CELL PRIMING FROM THE FIRST-IN-MAN SINGLE ASCENDING DOSE STUDY OF PEPTIDE COPOLYMER PI-2301 FOR THE TREATMENT OF MULTIPLE SCLEROSIS" on September 18, 2008 in Montreal, Quebec at the World Congress on Treatment and Research in Multiple Sclerosis from 3:30 p.m. - 5:00 p.m.
Peptimmune to Present at BIO 2008 Business Forum Wednesday, June 18th at 9:00 a.m.
Event Date: June 18, 2008
Thomas P. Mathers, president and CEO, will provide a corporate overview of Peptimmune and its PI-2301 peptide copolymer program at the Biotechnology Industry Organization's International Meeting in San Diego, CA. The presentation is part of the BIO Business Forum and is scheduled for 9:00 a.m. - 9:30 a.m. in Room 2 at the San Diego Convention Center, with a break out session to follow.
Peptimmune Presentation at 18th European Neurological Society in Nice, France
Event Date: June 09, 2008
Dr. Eric Zanelli, vice president of research, will present data from Peptimmune's PI-2301 peptide copolymer program for the treatment of multiple sclerosis.
Peptimmune Presentation at FOCIS
Event Date: June 07, 2008
Dr. Joseph Kovalchin, senior scientist, will present information on PI-2301 peptide copolymer for the treatment of multiple sclerosis at the Federation of Clinical Immunology Societies (FOCIS) 2008 meeting in Boston, MA.
